期刊文献+

毛细管电泳技术在多发性骨髓瘤诊断及MRD监测中的价值 被引量:7

Clinical significance of capillary electrophoresis in the diagnosis and MRD monitoring of patients with multiple myeloma
下载PDF
导出
摘要 目的:探讨毛细管电泳免疫分型技术在多发性骨髓瘤初诊及微小残留病变(MRD)监测中的意义。方法:采用毛细管电泳免疫分型技术对临床疑似由单克隆免疫球蛋白增多引起的肾病、血液病等初诊患者671例进行血清检测。连续追踪32例初诊诊断为多发性骨髓瘤的患者,毛细管分型电泳监测MRD,并与流式细胞仪监测结果进行对比。结果:单克隆免疫球蛋白增多者265例,阳性率39.5%,其中Ig G-κ型91例(34.3%),Ig G-λ型57例(21.5%),Ig A-κ型25例(9.4%),Ig A-λ型20例(7.5%),Ig M-κ型16例(6.0%),Ig M-λ型5例(1.9%),游离κ轻链型12例(4.5%),游离λ轻链型26例(9.8%),双克隆型11例(4.2%),其它型2例(0.8%)。连续监测32例多发性骨髓瘤患者MRD,患者诱导化疗缓解后3个月毛细管电泳MRD监测阳性率为46.9%,流式细胞仪阳性率为75.0%,两种方法比较,差异有显著性(P<0.05);诱导化疗缓解后6个月毛细管电泳MRD监测阳性率为28.1%,流式细胞仪阳性率为43.8%,两种方法比较无显著性差异。结论:毛细管电泳免疫分型技术对多发性骨髓瘤的诊断具有较高的敏感性及特异性,MRD监测虽不及流式细胞仪灵敏,但与流式细胞仪同时监测可减少漏检率。 Objective: To explore the clinical significance of capillary electrophoresis in the diagnosis and MRD monitoring of patients with multiple myeloma(MM).Methods: The serum of 671 patients with renal disease and blood disease doubtful caused by monoclonal immunoglobulin were extracted and detected by capillary immunoassay.We continuously followed up 32 patients with multiple myeloma.Capillary electrophoresis was used to monitor minimal residual disease,and the results were compared with flow cytometry.Results: Among all the samples,monoclonal immunoglobulin could be detected in 2 6 5 cases,the positive rate was 39.5%.It contained IgG kappa type in 91 cases(34.3%),IgG lambda type in 57 cases(21.5%),Ig A kappa type in 25 cases(9.4%),Ig A lambda type in 20cases(7.5%),IgM kappa type in 16 cases(6.0%),IgM lambda type in 5 cases(1.9%),free kappa light chain type in 12 cases(4.5%) and free lambda light chain type in 26 cases(9.8%),Bi clonal type in 11 cases(4.2%),the other 2 cases(0.8%).When the 32 patients with multiple myeloma achieved complete remission after chemotherapy,we performed continuous follow-up.After three months,the MRD positive rate of capillary electrophoresis was 46.9%and the MRD positive rate of flow cytometry was 75.0%.The difference between the two methods was significant(p〈0.05).After six months,the MRD positive rate of capillary electrophoresis was 28.1% and the MRD positive rate of flow cytometry was 43.8%.There was no statistics difference between the two methods.Conclusion: The capillary electrophoresis can diagnosis multiple myeloma with high sensitivity and specificity.Capillary electrophoresis of MRD monitoring is not as sensitive as flow cytometry,but CE and flow cytometry detection at the same time could reduce the miss rate.
出处 《现代肿瘤医学》 CAS 2017年第8期1300-1302,共3页 Journal of Modern Oncology
关键词 多发性骨髓瘤 毛细管电泳 单克隆免疫球蛋白 MRD multiple myeloma capillary electrophoresis monoclonal immunoglobulin MRD
  • 相关文献

参考文献4

二级参考文献31

  • 1Alegre A,Diaz-Mediavilla J,San Miguel J,et al.Autologous peripheral blood stem cell transplantation for multiple myeloma:a report of 259 cases from the spanish registry[J].Bone Marrow Transplant,1998,21(Suppl 1):113-140.
  • 2Adnan AZ,David HV.Multiple myeloma:an old disease with new hope for the future[J].Can Cancer J Clin,2001,51(5):273-285.
  • 3Chilosi M,Adami F,Lestani M,et al.CD138/syndecan-1 a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies[J].Mod Pathol,1999,12(12):1101-1106.
  • 4Wei A,Juneja S.Bone marrow immunohistology of plasma cell neoplasms[J].J Clin Pathol,2003,56(6):406-411.
  • 5Dworzak MN,Frosch IG,Printz D,et al.Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia[J].Blood,2002,99(6):1952-1958.
  • 6Pontet F. A data base for 3000 monoclonal immunoglobu- lin cases and a new classiticationLJ]. Clin Cbim Aeta, 2005,355(1/2) : 13-21.
  • 7Anguille S, Bryant C. Monoclonal gammopathy of unde- termined signifieance[J]. CMAJ, 2013,185 (15): 1345.
  • 8Attal M, Lauwers Cances V, Marit G, et al. Lenalidomide mainte- nance after stem - cell transplantation for multiple myeloma [ J ]. N Eng J Med,2012,366 (19) : 1782 - 1791.
  • 9McCarthy PL, Owzar K, Hofmeister CC, et al. Lenalidomide after stem - cell transplantation for multiple myeloma [ J ]. N Eng J Med,2012,366 (19) : 1770 - 1781.
  • 10Lohr JG, Stojanov P, Carter SL,et al. Widespread genetic heteroge- neity in multiple myeloma : Implications for targeted therapy [ J ]. Cancer Ce11,2014,25 ( 1 ) :91 - 101.

共引文献32

同被引文献67

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部